Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Peladawnon Jun 19, 2024 4:31pm
76 Views
Post# 36096666

RE:RE:RE:RE:RE:RE:expiration of options

RE:RE:RE:RE:RE:RE:expiration of options

Finally Notable and I agree on something.....the past email trail with Notable has proven beyond any doubt that Notable is bent on parroting the same lies told by the Democrat Party and then faithfully repeated relentlessly by the disgustingly corrupt mainstream media. Anyone who has any interest in the truth doesn't cherry-pick, the cut and past only the articles that suit their agenda even when those articles have been proven to be nothing but lies. To attack my integrity and character is simply another lie, and unfortunately so typical of the hypocracy of the left wing. Everything I posted was the truth and I will never post anything but the truth....like this article as another example

Documents have shown the FBI invested significant resources attempting to corroborate the dossier and relied substantially on it to obtain surveillance warrants targeting the former Trump campaign aide Carter Page.

But since its publication, core aspects of the dossier have been exposed as unsupported and unproven rumors. A special counsel assigned to investigate the origins of the Trump-Russia investigation charged one of Steele’s sources with lying to the FBI and charged a cybersecurity lawyer who worked for Clinton’s campaign with lying to the FBI during a 2016 meeting in which he relayed concerns about the Russia-based Alfa Bank

 

<< Previous
Bullboard Posts
Next >>